AstraZeneca faces increasingly tough evergreening battle in India
A recent Delhi court decision is a reminder of the tight restrictions around species and follow-on patents in the country
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.